OA09454A - Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. - Google Patents

Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Info

Publication number: OA09454A
Authority: OA; OAPI
Prior art keywords: contain; pharmaceutical compositions; preparation process; peptide derivatives; denotes
Prior art date: 1989-06-29

Application number

OA59814A

Other languages

English (en)

French (fr)

Inventor

Vincent Michel

Remond Georges

Portevin Bernard

Herve Yolande

Lepagnol Jean

Biton Catherine

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-29

Filing date

1990-06-28

Publication date

1992-10-15

1990-06-28 Application filed by Adir filed Critical Adir

1992-10-15 Publication of OA09454A publication Critical patent/OA09454A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
229910052799 carbon Inorganic materials 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
-1 4-imidazolylmethyl group Chemical group 0.000 abstract 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
238000002483 medication Methods 0.000 abstract 1
125000003367 polycyclic group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

OA59814A 1989-06-29 1990-06-28 Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. OA09454A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR898908672A FR2649110B1 (fr)	1989-06-29	1989-06-29	Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
OA09454A true OA09454A (fr)	1992-10-15

Family

ID=9383248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA59814A OA09454A (fr)	1989-06-29	1990-06-28	Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Country Status (15)

Country	Link
US (1)	US5098888A (de)
EP (1)	EP0406119B1 (de)
JP (1)	JPH0348695A (de)
AT (1)	ATE100464T1 (de)
AU (1)	AU627898B2 (de)
CA (1)	CA2019633A1 (de)
DE (1)	DE69006116T2 (de)
DK (1)	DK0406119T3 (de)
ES (1)	ES2062443T3 (de)
FR (1)	FR2649110B1 (de)
IE (1)	IE65156B1 (de)
NZ (1)	NZ233908A (de)
OA (1)	OA09454A (de)
PT (1)	PT94537A (de)
ZA (1)	ZA904495B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2663336B1 (fr) *	1990-06-18	1992-09-04	Adir	Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5388555A (en) *	1992-04-03	1995-02-14	Honda Giken Kogyo Kabushiki Kaisha	Outboard engine assembly
FR2694295B1 (fr) *	1992-07-28	1994-09-02	Adir	Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994026107A1 (en) *	1993-05-13	1994-11-24	New York University	Psychosis protecting nucleic acid, peptides, compositions and method of use
FR2710066B1 (fr) *	1993-09-14	1995-10-20	Synthelabo	Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
CA2245145A1 (en) *	1996-02-05	1997-08-07	Eli Lilly And Company	Method of treating beta-amyloid peptide associated conditions using trh
US5834458A (en) *	1996-10-09	1998-11-10	Eli Lilly And Company	Heterocyclic compounds and their use
KR100373825B1 (ko) *	2000-02-29	2003-02-26	(주)일산금속	자전거의 완충장치
US20030114420A1 (en) *	2000-06-28	2003-06-19	Salvati Mark E.	Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) *	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
IL152719A0 (en)	2000-06-28	2003-06-24	Bristol Myers Squibb Co	Selective androgen receptor modulators and methods for their identification
US7001911B2 (en) *	2000-06-28	2006-02-21	Bristol-Myers Squibb Company	Fused cyclic modulators of nuclear hormone receptor function
US6953679B2 (en)	2000-09-19	2005-10-11	Bristol-Myers Squibb Company	Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (de) *	2000-09-19	2007-11-28	Bristol-Myers Squibb Company	Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
US20040087548A1 (en)	2001-02-27	2004-05-06	Salvati Mark E.	Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
HUP0500096A3 (en) *	2001-12-19	2012-08-28	Bristol Myers Squibb Co	Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function, process for producing them and pharmaceutical compositions containing them
AU2005238386A1 (en)	2004-04-30	2005-11-10	Takeda Pharmaceutical Company Limited	Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
CN102432616B (zh) *	2011-11-23	2014-12-17	河北博伦特药业有限公司	一种制备l-脯氨酰胺及其中间体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1523598A (en) *	1975-03-08	1978-09-06	Reckitt & Colmann Prod Ltd	Tripeptides
HU180926B (en) *	1979-06-28	1983-05-30	Richter Gedeon Vegyeszet	Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
FR2575753B1 (fr) *	1985-01-07	1987-02-20	Adir	Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IT1184164B (it) *	1985-03-19	1987-10-22	Eniricerche Spa	Triptidi ad azione ipotensiva e procedimento per la loro sintesi
FR2585709B1 (fr) *	1985-08-05	1987-10-02	Adir	Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU595309B2 (en) *	1986-05-09	1990-03-29	Dainippon Pharmaceutical Co. Ltd.	Tripeptide derivatives
US4814342A (en) *	1986-10-31	1989-03-21	Pfizer Inc.	Nor-statine and nor-cyclostatine polypeptides
US4956344A (en) *	1987-09-17	1990-09-11	Hafslund Nycomed A/S	Method for treatment of lesions in the large intestinal epithelium with a tripeptide

1989
- 1989-06-29 FR FR898908672A patent/FR2649110B1/fr not_active Expired - Fee Related
1990
- 1990-06-01 NZ NZ233908A patent/NZ233908A/en unknown
- 1990-06-11 ZA ZA904495A patent/ZA904495B/xx unknown
- 1990-06-11 US US07/536,193 patent/US5098888A/en not_active Expired - Fee Related
- 1990-06-12 IE IE210390A patent/IE65156B1/en not_active IP Right Cessation
- 1990-06-22 CA CA002019633A patent/CA2019633A1/fr not_active Abandoned
- 1990-06-28 JP JP2168632A patent/JPH0348695A/ja active Pending
- 1990-06-28 PT PT94537A patent/PT94537A/pt not_active Application Discontinuation
- 1990-06-28 OA OA59814A patent/OA09454A/xx unknown
- 1990-06-28 AU AU57911/90A patent/AU627898B2/en not_active Ceased
- 1990-06-29 EP EP90401877A patent/EP0406119B1/de not_active Expired - Lifetime
- 1990-06-29 DE DE69006116T patent/DE69006116T2/de not_active Expired - Fee Related
- 1990-06-29 ES ES90401877T patent/ES2062443T3/es not_active Expired - Lifetime
- 1990-06-29 AT AT90401877T patent/ATE100464T1/de not_active IP Right Cessation
- 1990-06-29 DK DK90401877.7T patent/DK0406119T3/da active

Also Published As

Publication number	Publication date
DK0406119T3 (da)	1994-03-21
US5098888A (en)	1992-03-24
DE69006116T2 (de)	1994-07-28
PT94537A (pt)	1991-02-08
EP0406119A1 (de)	1991-01-02
IE65156B1 (en)	1995-10-04
NZ233908A (en)	1992-06-25
EP0406119B1 (de)	1994-01-19
ES2062443T3 (es)	1994-12-16
IE902103A1 (en)	1991-01-02
AU5791190A (en)	1991-01-03
AU627898B2 (en)	1992-09-03
IE902103L (en)	1990-12-29
CA2019633A1 (fr)	1990-12-29
FR2649110B1 (fr)	1994-10-21
JPH0348695A (ja)	1991-03-01
ATE100464T1 (de)	1994-02-15
FR2649110A1 (fr)	1991-01-04
ZA904495B (en)	1991-03-27
DE69006116D1 (de)	1994-03-03

Similar Documents

Publication	Publication Date	Title
OA09368A (fr)	1992-09-15	"Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
OA09454A (fr)	1992-10-15	Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
OA08182A (fr)	1987-10-30	Nouveaux dérivés peptidiques à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0648778A3 (de)	1995-08-09	Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel.
FI893750A0 (fi)	1989-08-09	Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
EP1108427A3 (de)	2004-01-07	Zusammensetzungen mit Phenylacetat und dessen Derivaten und deren Verwendung zur Veränderung der Genexpression
HU906284D0 (en)	1991-03-28	Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
EP0648779A3 (de)	1995-08-09	Neue 11-Benzaldoxim-17beta methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel.
CA2003289A1 (en)	1990-05-18	Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
DE3850603D1 (de)	1994-08-18	Arylaralkylether, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung.
KR880000432A (ko)	1988-03-25	4(3H)-옥소-5,6,7,8-테트라히드로피리도-2,3-d 피리미딘 유도체
OA09349A (fr)	1992-09-15	"Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
OA08972A (fr)	1990-11-30	Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leursprocédés de préparation et les compositions pharmaceutiques qui les contiennent
OA09460A (fr)	1992-11-15	"Nouveaux dérivés d'oxazolo pyridines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
OA08881A (fr)	1989-10-31	Nouveaux tripeptides à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
OA09416A (fr)	1992-10-15	Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
OA09147A (fr)	1991-10-31	Nouveaux dérivés de l'indole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
KR950702566A (ko)	1995-07-29	사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
OA09299A (fr)	1992-09-15	Nouveaux dérivés N- (vincristinoyl-23) et N- (noranhydro-5' vinblastinoyl-23) d'acide animo-1 méthylphosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DZ1366A1 (fr)	2004-09-13	Nouveaux dérivés de la méthoxycarbonyl-2 n,n'-di-(triméthoxybenzoyle) pipérazine, ainsi que leur procédé de préparation.
OA09127A (fr)	1991-10-31	Nouveaux dérivés de benzopyrrolidinone, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2711651B1 (fr)	1995-12-22	Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
PT86422A (fr)	1988-01-01	Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant
KR890001528A (ko)	1989-03-27	성인 t-세포 백혈병/임파종의 억제를 위한 아바론, 아바롤 및 그 유도체의 용도
KR890001527A (ko)	1989-03-27	에이즈 및 에이즈 관련 복합증상의 억제를 위한 아바콘, 아바롤 및 그 유도체의 용도